Protein-Protein Interactions
Protein-Protein Interactions
Michael D. Wendt
Protein-Protein Interactions as Drug Targets
Shaomeng Wang , Yujun Zhao , Denzil Bernard , Angelo Aguilar , Sanjeev Kumar
Targeting the MDM2-p53 Protein-Protein Interaction for New Cancer Therapeutics
Kurt Deshayes , Jeremy Murray , Domagoj Vucic
The Development of Small-Molecule IAP Antagonists for the Treatment of Cancer
John F. Kadow , David R. Langley , Nicholas A. Meanwell , Michael A. Walker , Kap-Sun Yeung , Richard Pracitto
Protein-Protein Interaction Targets to Inhibit HIV-1 Infection
Nicholas A. Meanwell , David R. Langley
Inhibitors of Protein-Protein Interactions in Paramyxovirus Fusion - a Focus on Respiratory Syncytial Virus
Andrew B. Mahon , Stephen E. Miller , Stephen T. Joy , Paramjit S. Arora
Rational Design Strategies for Developing Synthetic Inhibitors of Helical Protein Interfaces
Michael D. Wendt
The Discovery of Navitoclax, a Bcl-2 Family Inhibitor
Protein-Protein Interactions as Drug Targets
Targeting the MDM2-p53 Protein-Protein Interaction for New Cancer TherapeuticsThe Development of Small-Molecule IAP Antagonists for the Treatment of Cancer
Protein-Protein Interaction Targets to Inhibit HIV-1 Infection
Inhibitors of Protein-Protein Interactions in Paramyxovirus Fusion - a Focus on Respiratory Syncytial Virus
Rational Design Strategies for Developing Synthetic Inhibitors of Helical Protein Interfaces
The Discovery of Navitoclax, a Bcl-2 Family Inhibitor.
Wendt, Michael D.
| ISBN | 978-3-642-43955-1 |
|---|---|
| Medientyp | Buch |
| Copyrightjahr | 2014 |
| Verlag | Springer, Berlin |
| Umfang | XVIII, 262 Seiten |
| Sprache | Englisch |
